pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Small Molecules
drug
save

Small Molecules

Preclinicalupdated 6mo ago
by Vincere Biosciences Inc
Preclinical
community read0 votes

🐶 often sniffed alongside

top 2
  • tagDermatology1 co-mentions · 1 sources
  • tagMicrobiome1 co-mentions · 1 sources

indications

indications
Parkinson's Disease

all catalysts(0)

nothing on the calendar yet

News(10)

  • STAT+: Lawmakers want U.S. biotech to outcompete China
    Lawmakers leading the congressional BIOTech Caucus say Washington needs to act in the sector — and fast:
    stat · 3h ago
  • nChroma halves workforce, BioXcel lets execs go
    Follow along as BioSpace tracks job cuts and restructuring initiatives.
    biospace · 5h ago
  • With FDA nod, Regeneron brings an RNAi drug to autoimmune disease
    The product of a collaboration with Alnylam, Livsayis is now Regeneron’s first marketed RNAi drug and will compete against established medicines from AstraZeneca and Argenx.
    biopharma_dive · 5h ago
  • STAT+: Merck, Isomorphic Labs partner to develop oncology drug candidates
    Merck and Isomorphic Labs said they are entering into a research collaboration to discover small molecule candidates in oncology.
    stat · 8h ago
  • Isomorphic adds Merck to AI drug discovery roster days after $5B raise
    Isomorphic Labs’ big week just got bigger. Days after raising $5 billion, the AI-powered biotech has added Merck & Co. to a list of partners that now includes three of the top four drugmakers by re…
    fiercebiotech · 11h ago
  • FDA publishes rejection letter for Summit drug; Nuvalent buyout pays more dividends for GSK
    The FDA had several issues with ivonescimab, according to the letter. Elsewhere, Sellas shares rocketed on results for a leukemia vaccine and Biogen and Lilly struck up new R&D pacts.
    biopharma_dive · 1d ago
  • Scientists uncover ‘very detailed map’ of an enzyme target for rare metabolic disease
    For some rare genetic diseases, the problem isn't a missing protein but the buildup of toxic molecules that the body can no longer clear away.
    fiercebiotech · 2d ago
  • The promise of molecular gates and what comes next
    Gate Bioscience is developing a new class of medicines designed to eliminate disease-causing proteins at their source. In this episode of "The Top Line," Gate co-founder and CEO Jordi Mata-Fink, Ph…
    fiercebiotech · 6d ago
  • Charles River pays $470M for 2 Frontage bioanalysis labs in Pennsylvania
    Charles River Laboratories has acquired Tigermed’s Frontage laboratory sites for $470 million upfront to advance its bioanalysis footprint.
    fiercebiotech · 6d ago
  • London biotech Oyster harvests $60M for tau-targeting brain drugs
    Oyster says a tweak it's made to traditional protein degrading technology can help break down tau, which has long been a focus of Alzheimer’s drug research.
    biopharma_dive · 9d ago
view all news mentions →
indication
Parkinson's Disease
phase
preclinical
Data sources
ClinicalTrials.gov
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?